Teva USA — Medicare Part D spending
Rank #18 by attributed Part D spend · 89 tracked drugs · CMS data year 2023
About $3,282,138,915 of Medicare Part D spending in 2023 is attributed to Teva USA across the 89 of its drugs tracked here, ranking it #18 among manufacturers on this site. Its biggest Part D drug is Austedo at $1,123,439,045. Attribution uses the CMS manufacturer lists and is indicative, not definitive. These are aggregate program figures, not the price you pay.
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
Teva USA drugs in Medicare Part D (2023)
| Brand | Generic | Total spend | Per dosage unit | Beneficiaries | Spend rank |
|---|---|---|---|---|---|
| <a href="/drug/austedo-deutetrabenazine/">Austedo</a> | Deutetrabenazine | $1,123,439,045 | $103.61 | 18,283 | #42 |
| <a href="/drug/trazodone-hcl-trazodone-hcl/">Trazodone HCl</a> | Trazodone HCl | $216,388,379 | $0.21 | 3,666,058 | #208 |
| <a href="/drug/famotidine-famotidine/">Famotidine*</a> | Famotidine | $202,810,000 | $0.20 | 3,593,191 | #215 |
| <a href="/drug/pravastatin-sodium-pravastatin-sodium/">Pravastatin Sodium</a> | Pravastatin Sodium | $183,603,098 | $0.26 | 2,403,267 | #243 |
| <a href="/drug/buspirone-hcl-buspirone-hcl/">Buspirone HCl</a> | Buspirone HCl | $134,026,927 | $0.20 | 1,420,432 | #317 |
| <a href="/drug/epinephrine-epinephrine/">Epinephrine</a> | Epinephrine | $133,365,359 | $124.71 | 413,026 | #318 |
| <a href="/drug/carbidopa-levodopa-carbidopa-levodopa/">Carbidopa-Levodopa</a> | Carbidopa/Levodopa | $125,111,276 | $0.20 | 537,069 | #338 |
| Diclofenac Epolamine | Diclofenac Epolamine | $103,403,812 | $10.71 | 34,754 | #380 |
| Clonazepam | Clonazepam | $81,576,407 | $0.17 | 1,317,240 | #455 |
| Naloxone HCl* | Naloxone HCl | $71,560,437 | $40.02 | 744,446 | #500 |
| Warfarin Sodium | Warfarin Sodium | $70,883,350 | $0.20 | 942,245 | #502 |
| Atenolol | Atenolol | $70,694,566 | $0.12 | 1,630,835 | #505 |
| Cephalexin | Cephalexin | $64,269,317 | $0.37 | 5,051,787 | #537 |
| Ajovy Autoinjector | Fremanezumab-Vfrm | $62,638,824 | $466.57 | 14,658 | #546 |
| Torsemide | Torsemide | $62,185,203 | $0.27 | 675,579 | #548 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | $61,462,807 | $0.70 | 223,418 | #552 |
| Azithromycin* | Azithromycin | $59,585,357 | $0.98 | 5,970,026 | #566 |
| Rasagiline Mesylate | Rasagiline Mesylate | $43,873,454 | $5.34 | 30,404 | #648 |
| Icatibant | Icatibant Acetate | $43,631,103 | $1,697.66 | 546 | #650 |
| Mupirocin | Mupirocin | $33,820,823 | $0.41 | 2,467,308 | #749 |
| Olmesartan-Amlodipine-HCTZ | Olmesartan/Amlodipin/HCThiazid | $29,932,738 | $2.94 | 37,961 | #790 |
| Budesonide* | Budesonide | $29,899,549 | $2.62 | 32,957 | #791 |
| Diltiazem HCl* | Diltiazem HCl | $25,260,605 | $0.32 | 197,018 | #867 |
| Mesalamine Dr | Mesalamine | $25,241,896 | $2.36 | 9,934 | #868 |
| Ajovy Syringe | Fremanezumab-Vfrm | $24,907,349 | $486.72 | 5,556 | #876 |
| Cilostazol | Cilostazol | $23,275,119 | $0.27 | 199,211 | #899 |
| Nortriptyline HCl | Nortriptyline HCl | $23,070,730 | $0.22 | 302,986 | #905 |
| Venlafaxine HCl | Venlafaxine HCl | $22,736,622 | $0.37 | 167,773 | #912 |
| Loperamide | Loperamide HCl | $22,281,039 | $0.39 | 389,634 | #921 |
| Clozapine ODT | Clozapine | $18,620,763 | $9.51 | 2,860 | #986 |
| Mexiletine HCl | Mexiletine HCl | $13,384,808 | $1.14 | 20,421 | #1115 |
| Metoclopramide HCl* | Metoclopramide HCl | $10,453,313 | $0.11 | 402,098 | #1210 |
| Adderall | Dextroamphetamine/Amphetamine | $9,672,998 | $10.17 | 4,019 | #1249 |
| Cabergoline | Cabergoline | $8,645,908 | $7.10 | 19,362 | #1290 |
| Cimetidine | Cimetidine | $7,751,019 | $0.82 | 29,869 | #1331 |
| Cyclosporine Modified | Cyclosporine, Modified | $7,444,367 | $1.40 | 8,802 | #1353 |
| Glyburide | Glyburide | $4,681,144 | $0.16 | 59,131 | #1522 |
| Penciclovir | Penciclovir | $3,183,178 | $112.57 | 3,267 | #1671 |
| Danazol | Danazol | $2,660,888 | $4.17 | 1,840 | #1745 |
| Fentanyl Citrate | Fentanyl Citrate | $2,179,042 | $25.13 | 78 | #1814 |
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
Frequently asked questions
How much Medicare Part D spending does Teva USA get?
In 2023, about $3,282,138,915 of Medicare Part D spending is attributed to Teva USA across the 89 of its drugs tracked here. Its biggest is Austedo at $1,123,439,045. This is gross program spending, not what patients pay. Source: CMS, data year 2023.
What is Teva USA's top Medicare Part D drug?
Among the drugs tracked here, Teva USA's highest Part D spending in 2023 is Austedo at $1,123,439,045 (national rank #42 by total spend).
Is manufacturer attribution exact?
No. CMS may list multiple manufacturers per drug, and labeler relationships change over time. We attribute each drug to its primary listed manufacturer, so these rollups are indicative rather than definitive. Always check the underlying CMS file for a specific drug.
Keep exploring
Data: CMS Medicare Part D Spending by Drug (data year 2023), U.S. public domain. Aggregate program spending, not prices. Data as of June 2026. See our methodology and disclaimer.
Last updated: 2026-06-21